Macada Holding, Inc. Announces Its Board of Directors Has Approved the Subsidiary LyfeTec to Engage the South Florida Laboratory

   Macada Holding

,

 Inc. (PINKSHEETS: MCDA) announces its board of directors have approved the subsidiary LyfeTec to engage the South Florida laboratory to begin manufacturing our Bio-Skin line.

LyfeTec officers and our Bio-Chemist Karsten Klingelhoeller are working on the formula's first batch to be manufactured for sales with the top South Florida cosmetic laboratory (soon to be announced) with regards to outsourcing the manufacturing of the Bio-Skin line which help treat skin diseases.

Its subsidiary LyfeTec, Inc.'s new product line, Bio-Skin's website, is accepting and has to date generated orders. LyfeTec is now branding the website www.bio-skin.us and marketing sales over the internet at this time. Over the week of testing we launched the Bio-Skin site to begin generating revenues and have made sales. Consumers can now purchase the products for orders while manufacturing is in place.

Anthony Mellone stated, "We believe that the course of the manufacturing shall be completed within 30 days and we require a 6 to 7 week delivery schedule for a turnaround time. We feel the website will increase revenues once branded over the next several weeks. The LyfeTec Management is now working on signing an agreement with a major marketing company to sell Bio-Skin worldwide."

Safe Harbor Provision

This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties and events that may be beyond the control of Macada Holding, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, the availability of technical personnel, changes in technology and competition.

Contact: Ron Ritter 954-782-2056